Skip to main content
. 2016 Jul 14;2016:5083841. doi: 10.1155/2016/5083841

Table 3.

Clinicopathological characteristics of gastric cancer samples and ADAMTS8 methylation.

Variable Patients (n) ADAMTS8 methylation P value
M (%) U (%)
Age (years)
 <65 40 25 (62.5) 15 (37.5)
 ≥65 26 15 (57.7) 11 (42.3) 0.365
Gender
 Male 45 29 (64.4) 16 (35.6)
 Female 21 11 (52.4) 10 (47.6) 0.219
Tumor differentiation
 Well/moderate 33 23 (69.7) 10 (30.3)
 Poor 33 17 (51.5) 16 (48.5) 0.614
Invasive depth
 T1 + T2 22 10 (40.9) 12 (59.1)
 T3 + T4 44 30 (70.5) 14 (29.5) 0.075
Tumor location
 Upper + middle 13 8 (61.5) 5 (38.5)
 Lower 53 32 (60.4) 21 (39.6) 0.478
Size (cm)
 <3 28 15 (53.6) 13 (46.4)
 ≥3 38 25 (65.8) 13 (34.2) 0.621
Lymph node metastasis
 No 20 7 (35.0) 13 (65.0)
 Yes 46 33 (71.3) 13 (28.7) 0.005a

a P < 0.05. M: methylated and partially methylated cases; U: unmethylated cases; ADAMTS8: ADAM metallopeptidase with thrombospondin type 8 motif.